PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Texas at Dallas, School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, Pain Neurobiology Research Group, USA. Electronic address: prr105020@utdallas.edu.\', \'University of Texas at Dallas, School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, Pain Neurobiology Research Group, USA.\', \'University of Cincinnati, College of Medicine, Department of Anesthesiology, USA.\', \'University of Texas at Dallas, School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, Neuroimmunology and Behavior Research Group, USA.\', \'University of Texas at Dallas, School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, Pain Neurobiology Research Group, USA. Electronic address: theodore.price@utdallas.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0889-1591(20)30670-X10.1016/j.bbi.2020.05.078
?:hasPublicationType
?:journal
  • Brain, behavior, and immunity
is ?:pmid of
?:pmid
?:pmid
  • 32497778
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.78
?:rankingScore_hIndex
  • 119
is ?:relation_isRelatedTo_publication of
?:title
  • A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all